Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection

Mycobacterium kansasii is the second most commonly occurring Non-Tuberculous Mycobacteria (NTM) in the United States. Infection is typically seen in middle aged males, and the risk of infection is greatly increased in immunocompromised hosts. Pulmonary infection presents in clinical parallel to that...

Full description

Bibliographic Details
Main Authors: Amit Toor, Gerson De Freitas, Jorge Torras
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Respiratory Medicine Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007119300656
id doaj-d709925d74e742e2b39deb27cf3c86eb
record_format Article
spelling doaj-d709925d74e742e2b39deb27cf3c86eb2020-11-25T01:11:34ZengElsevierRespiratory Medicine Case Reports2213-00712019-01-0127Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infectionAmit Toor0Gerson De Freitas1Jorge Torras2Corresponding author.; Internal Medicine Resident, Internal Medicine Department, Easton Hospital, Easton, PA, 18042, USAInternal Medicine Resident, Internal Medicine Department, Easton Hospital, Easton, PA, 18042, USAInternal Medicine Resident, Internal Medicine Department, Easton Hospital, Easton, PA, 18042, USAMycobacterium kansasii is the second most commonly occurring Non-Tuberculous Mycobacteria (NTM) in the United States. Infection is typically seen in middle aged males, and the risk of infection is greatly increased in immunocompromised hosts. Pulmonary infection presents in clinical parallel to that of Mycobaterium tuberculosis (TB) and is therefore often misdiagnosed. A combination of clinical, radiological, and microbiological evidence of infection is generally required to clinch the diagnosis. Treatment of such cases include prolonged courses of rifampin in combination with 2 other antimicrobial agents. The overall prognosis with appropriate treatment is good with the exception of disseminated disease in severely immunocompromised hosts. In patients who are misdiagnosed or undertreated, there is progressive destruction of the lung parenchyma with distortion of lung architecture. This can in-turn lead to bronchiectatic changes leaving the airways exposed to devastating superimposed bacterial pneumonia. We describe a case of a patient with untreated M. kansasii infection who developed superimposed necrotizing pneumonia and respiratory failure requiring prolonged ventilatory support.http://www.sciencedirect.com/science/article/pii/S2213007119300656
collection DOAJ
language English
format Article
sources DOAJ
author Amit Toor
Gerson De Freitas
Jorge Torras
spellingShingle Amit Toor
Gerson De Freitas
Jorge Torras
Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
Respiratory Medicine Case Reports
author_facet Amit Toor
Gerson De Freitas
Jorge Torras
author_sort Amit Toor
title Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
title_short Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
title_full Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
title_fullStr Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
title_full_unstemmed Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
title_sort necrotizing pneumonia in a patient with untreated mycobacterium kansasii infection
publisher Elsevier
series Respiratory Medicine Case Reports
issn 2213-0071
publishDate 2019-01-01
description Mycobacterium kansasii is the second most commonly occurring Non-Tuberculous Mycobacteria (NTM) in the United States. Infection is typically seen in middle aged males, and the risk of infection is greatly increased in immunocompromised hosts. Pulmonary infection presents in clinical parallel to that of Mycobaterium tuberculosis (TB) and is therefore often misdiagnosed. A combination of clinical, radiological, and microbiological evidence of infection is generally required to clinch the diagnosis. Treatment of such cases include prolonged courses of rifampin in combination with 2 other antimicrobial agents. The overall prognosis with appropriate treatment is good with the exception of disseminated disease in severely immunocompromised hosts. In patients who are misdiagnosed or undertreated, there is progressive destruction of the lung parenchyma with distortion of lung architecture. This can in-turn lead to bronchiectatic changes leaving the airways exposed to devastating superimposed bacterial pneumonia. We describe a case of a patient with untreated M. kansasii infection who developed superimposed necrotizing pneumonia and respiratory failure requiring prolonged ventilatory support.
url http://www.sciencedirect.com/science/article/pii/S2213007119300656
work_keys_str_mv AT amittoor necrotizingpneumoniainapatientwithuntreatedmycobacteriumkansasiiinfection
AT gersondefreitas necrotizingpneumoniainapatientwithuntreatedmycobacteriumkansasiiinfection
AT jorgetorras necrotizingpneumoniainapatientwithuntreatedmycobacteriumkansasiiinfection
_version_ 1725170816477298688